Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of a transgenic mouse model of ALS

Neuroscience Research

Volumn 65, Issue 2, 2009, Pages 194-200

  Kadoyama, Keiichi ^a,b   Funakoshi, Hiroshi ^a   Ohya Shimada, Wakana ^a   Nakamura, Takahiro ^c   Matsumoto, Kunio ^c   Matsuyama, Shogo ^b   Nakamura, Toshikazu ^d  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HIMEJI DOKKYO UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

Amyotrophic lateral sclerosis (ALS); c Met HGF receptor (c Met); Hepatocyte growth factor (HGF); Neurotrophic; Phosphorylation; Protein phosphatase 2A (PP2A)

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; PHOSPHOPROTEIN PHOSPHATASE 2A; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SERINE; TYROSINE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SPINAL CORD MOTONEURON; TRANSGENIC MOUSE; UPREGULATION;

AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CATALYTIC DOMAIN; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FACIAL NERVE; GENE EXPRESSION REGULATION; HEPATOCYTE GROWTH FACTOR; HUMANS; MICE; MICE, TRANSGENIC; MOTOR NEURONS; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; PROTO-ONCOGENE PROTEINS C-MET; RHOMBENCEPHALON; SERINE; SUPEROXIDE DISMUTASE; TYROSINE;

EID: 68949150764     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2009.06.016     Document Type: Article

References (23)

1. Andreozzi F., Melillo R.M., Carlomagno F., Oriente F., Miele C., Fiory F., Santopietro S., Castellone M.D., Beguinot F., Santoro M., and Formisano P. Protein kinase Cα activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase. Oncogene 22 (2003) 2942-2949
2. Cleveland D.W., and Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2 (2001) 806-819
3. Ebens A., Brose K., Leonardo E.D., Hanson Jr. M.G., Bladt F., Birchmeier C., Barres B.A., and Tessier-Lavigne M. Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron 17 (1996) 1157-1172
4. Funakoshi H., and Nakamura T. Hepatocyte growth factor: from diagnosis to clinical applications. Clin. Chim. Acta 327 (2003) 1-23
5. Gandino L., Longati P., Medico E., Prat M., and Comoglio P.M. Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase. J. Biol. Chem. 269 (1994) 1815-1820
6. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., Chen W., Zhai P., Sufit R.L., and Siddique T. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
7. Hashigasako A., Machide M., Nakamura T., Matsumoto K., and Nakamura T. Bi-directional regulation of Ser-985 phosphorylation of c-met via protein kinase C and protein phosphatase 2A involves c-Met activation and cellular responsiveness to hepatocyte growth factor. J. Biol. Chem. 279 (2004) 26445-26452
8. Honda S., Kagoshima M., Wanaka A., Tohyama M., Matsumoto K., and Nakamura T. Localization and functional coupling of HGF and c-Met/HGF receptor in rat brain: implication as neurotrophic factor. Brain Res. Mol. Brain Res. 32 (1995) 197-210
9. Hu J.H., Chernoff K., Pelech S., and Krieger C. Protein kinase and protein phosphatase expression in the central nervous system of G93A mSOD overexpressing mice. J. Neurochem. 85 (2003) 422-431
10. Hunter T., Ling N., and Cooper J.A. Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane. Nature 311 (1984) 480-483
11. Ishigaki A., Aoki M., Nagai M., Warita H., Kato S., Kato M., Nakamura T., Funakoshi H., and Itoyama Y. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model. J. Neuropathol. Exp. Neurol. 66 (2007) 1037-1044
12. Kadoyama K., Funakoshi H., Ohya W., and Nakamura T. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS. Neurosci. Res. 59 (2007) 446-456
13. Lanius R.A., Paddon H.B., Mezei M., Wagey R., Krieger C., Pelech S.L., and Shaw C.A. A role for amplified protein kinase C activity in the pathogenesis of amyotrophic lateral sclerosis. J. Neurochem. 65 (1995) 927-930
14. Ma P.C., Maulik G., Christensen J., and Salgia R. c-Met: structure, functions and potential for therapeutic inhibition. Cancer Metast. Rev. 22 (2003) 309-325
15. Nakamura T., Nawa K., and Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 122 (1984) 1450-1459
16. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., Tashiro K., and Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature 342 (1989) 440-443
17. Pasinelli P., and Brown R.H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7 (2006) 710-723
18. Sontag E., Luangpirom A., Hladik C., Mudrak I., Ogris E., Speciale S., and White III C.L. Altered expression levels of the protein phosphatase 2A ABαC enzyme are associated with Alzheimer disease pathology. J. Neuropathol. Exp. Neurol. 63 (2004) 287-301
19. Sun W., Funakoshi H., and Nakamura T. Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS. J. Neurosci. 22 (2002) 6537-6548
20. Takayama S., White M.F., and Kahn C.R. Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. J. Biol. Chem. 263 (1988) 3440-3447
21. Van Kanegan M.J., and Strack S. The protein phosphatase 2A regulatory subunits B′β and B′δ mediate sustained TrkA neurotrophin receptor autophosphorylation and neuronal differentiation. Mol. Cell. Biol. 29 (2009) 662-674
22. Van Kanegan M.J., Adams D.G., Wadzinski B.E., and Strack S. Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt. J. Biol. Chem. 280 (2005) 36029-36036
23. Wang C., Chang K.C., Somers G., Virshup D., Ang B.T., Tang C., Yu F., and Wang H. Protein phosphatase 2A regulates self-renewal of Drosophila neural stem cells. Development 136 (2009) 2287-2296